List of high-quality authors
Tiancheng Technology: It is planned to repurchase the company's shares with 30 million yuan - 50 million yuan
Tiancheng Technology announced that it intends to repurchase the company's shares with 30 million yuan - 50 million yuan, and the repurchase of ** shares does not exceed 75 yuan, and the repurchased shares will be used for employee stock ownership plans or equity incentives at an appropriate time in the future.
Huashu Hi-Tech announced that the chairman proposed to repurchase shares for 10 million yuan to 20 million yuan.
Science and Technology Innovation: The actual controller proposed that the company repurchase shares for 20 million yuan to 40 million yuan
Keda Innovation announced that Dong Yongdong, the actual controller, chairman and general manager of the company, proposed that the company repurchase shares, which will be used for equity incentives or employee stock ownership plans, and the total amount of funds to repurchase shares shall not be less than 20 million yuan and not more than 40 million yuan.
Hytera: Won the bid for the procurement project of Shenzhen Metro special communication system equipment and related services
Hytera announced that it has won the bid for the procurement of special communication system equipment and related services for Shenzhen Metro, with a proposed bid amount of RMB 8,299940,000 yuan.
Huadong Medicine: Net profit in 2023 is expected to increase by 12 year-on-year5%β14.5%γ
Huadong Pharmaceutical released its 2023 annual performance forecast, and it is expected to achieve a net profit attributable to shareholders of listed companies of 28 in 20231.2 billion yuan - 286.2 billion yuan, a year-on-year increase of 125%β14.5%γThe overall business of medical cosmetology continued to maintain a momentum of rapid development, with operating income reaching the best level in history, and domestic and foreign businesses achieving good profitability, which brought positive contributions to the company's overall performance.